Friday, Oct 23, 2026
Focus on the big picture

J&J COVID-19 vaccine 66% effective globally

Reuters, 30 Jan 2021
Johnson & Johnson announced Friday that its single-dose vaccine was 66% effective globally in preventing COVID-19, and 72% effective in the United States. The company plans to seek emergency use authorization from the U.S. Food and Drug Administration next week

#COVID #COVID19 #Vaccine #VaccineWar #JNJ #Coronavirus

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles